chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Following the vaccine, patient woke up the next morning covered in puritic hives on his face, neck, bilateral antecubital regions of arms, bilateral axillary regions, and bilateral flank region.  Pt reports hives as "extremely itchy," and "feels like it burns."
Chills; Tired; This is a spontaneous report from a contactable consumer, the patient. A 39 -year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 09:00 AM (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to vaccination. The patient did not receive any other medications/vaccines within two weeks prior to the vaccination. On 21Mar2021 (first day), the patient was tired. On 23Mar2021 (three days after injection) at 03:30 AM, the patient experienced chills. The patient did not receive any treatment for the reported events. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tired and chills was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021 at 3:49 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 3:49 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 52.04 for dose administered on 14-Feb-2021.  No concomitant medications were reported. ~ Batch number 031L20A underwent temperature excursion on 12-Feb-2021 with temperature 35 degrees Fahrenheit from 10:00 AM to 11:00 AM, on 13-Feb-2021 with temperature 32 degrees Fahrenheit at 09:00 AM and 14-Feb-2021 with temperature 32,35 degrees Fahrenheit from 09:00 AM to 03:00 PM. This vial was moved to fridge on 09-Feb-2021 and beyond use date for the vial was reported as 10-Mar-2021. Product moved to clinic on 13-Jan-2021 and 12-Feb-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Fever, delirium, total body aches, chills, nausea.  The onset of delirium came with the temp as we were on a road trip in the car headed to a hockey tournament.  It was noticed by my spouse who is a physician and several other hockey parents. I looked up delirium as a side effect but could not find anything related with the exception of elderly or with COVID itself.  So I thought I should report it to see if it had been reported by anyone else. It lasted until I went to bed and fever came down that night.
The night of I experienced mild fever/ headache that lasted to the next day  5 days after the injection I began experiencing abdominal pains, nausea, and headaches every other day.   Wednesday was slight stomach ache Thursday was intense stomach ache, nausea, retching Friday was mild stomach ache Saturday was intense stomach aches, nausea, retching Sunday was fine, perhaps slight stomach ache Monday was uncomfortable stomach ache but not as intense as previously experienced, nausea  Tuesday, Wednesday, Thursday, Friday, mild to no symptoms.  Hard to tell.
Back of Left eye hurts, sinus near left eye feels swollen, mild headache; Back of Left eye hurts, sinus near left eye feels swollen, mild headache; Back of Left eye hurts, sinus near left eye feels swollen, mild headache; Back of Left eye hurts, sinus near left eye feels swollen, mild headache; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient started to receive BNT162B2 (also reported as " Pfizer COVID-19 Vaccine"), Lot number: EL0142, via an unspecified route of administration on 27Dec2020 18:45 at single dose (dose 1) in the left arm for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination, the patient has not been tested for COVID-19. Medical history included food allergies: shrimp. Concomitant medication included guaifenesin (MUCINEX). On 28Dec2020 06:00, the patient experienced back of left eye hurts, sinus near left eye feels swollen and mild headache. The outcome of the events was not recovered.
Customer went to the store requesting the vaccine PNEUMOVAX 23 which was applied on the left arm deltoid muscle. Pneumonia vaccine as well as the Influenza are only requested by the patient as no prescription is required. PNEUMOVAX with Lot K009876 had an expiration date of 03/19/2016. Prior administration of the vaccine, the patient filled out the VARS and marked off NO on all questions. Customer was administered the vaccine on 04/29/2015. Customer reports pain and itching on 04/30/2015 and she was informed by staff those were secondary common side effects, and if pain persist to visit an ER. Customer reported she applied ice and took RELAFEN. Customer went to Medico Offices across from store and they referred her to the ER. Customer sought medical attention at unknown ER on 05/01/2015. PNEUMOVAX 23 is manufactured by Merck and it is administered to patients ages 59 and above and to those patients whose respiratory system is compromised. A prefilled 0.5 ml injection was administered using a non-retractable needle but tip. Needle is 25 x 1 gauge and it was administered on the left deltoid muscle by staff with certification. Customer was vaccinated against Influenza on February of the current year. Client stated an adverse reaction to the vaccine would have included bronchospasm or anaphylactic shock. Furthermore, client stated the continuous itching of the area is more related to a possible allergic reaction to the liquid of the vaccine. Client provided all related documents such as the VARS and profile. She also stated the VAERS which is filled out online for the CDC when there is a report of an adverse/allergic reaction to the vaccine was completed, but client is unable to provide us with a copy of the form.
Pea-sized nodule above collar bone on same side as shot.  Experienced discomfort. Nodules also discovered in throat after examination.
Around 1am Tuesday, April 6th (the day after the vaccination), developed acute onset fever (Tm 102), chills, extreme muscle aches, profound malaise/fatigue, nausea/vomiting, and diarrhea.  Those symptoms lasted about 24 hours and, by midday Wednesday, she was back to her baseline of intermittent dry cough, shortness of breath, and no smell or taste.  It wasn't until Sunday, two days ago, that she developed sharp, pinpoint right superior parietal scalp pain that, after a few doses of OTC Aleve, did somewhat improve.  Other than two 220 mg OTC Aleve tabs twice daily, she has not been taking anything else for her symptoms other than prescribed asthma/allergy meds. She states that her shortness of breath has been helped from the use of albuterol as needed.  Unfortunately, the Aleve has not helped with her chest pain, which she describes as a "constant ache."  Initially, patient had some pleurisy, but that has apparently cleared up.     No history of CVT, PE, and she does not smoke or take oral contraceptives.
Starting a week after my first vaccination, I started having significant problems with dizziness, vertigo, and fatigue. I had been improving somewhat, but my second shot (March 13) knocked me down again, and the symptoms have been getting worse instead of better since then.
Narrative:  Patient is an 82 yo male with PMHx COPD, HLD, HTN, GERD with hx of esophageal stricture s/p dilation 2009), anemia, chronic venous htn, and RA who presented to MC ED 9/7/21 c/o difficulty swallowing food, nausea, and general malaise x several months, steadily worsening. SIRS 2/4, WBC 24.4 and HR 114 OA. CT a/p concerning for psoas abscess; surgery consulted and recommended IR. UA with infectious signs, air in the nephric space concerning for complicated UTI vs translocative infection in the setting of psoas abscess, started on vanc/cefepime. Patient was admitted for further work up and treatment. IR performed CT guided abscess drainage yesterday 9/9/2021 with successful placement of drain into left lower quadrant to drain the lateral inferior abscess, and successful placement of drain through the left flank to drain the perinephric abscess. GI performed EGD yesterday 9/9/21 and found intrinsic 8 mm stricture that was 5 cm long and appeared at 35 cm; dilated to 10mm. Additional findings suggestive of candidal esophagitis. Hospice and palliative medicine consulted for Goals of care. Patient is known to palliative medicine service from prior admission May 2021. Patient was transitioned to comfort care in inpatient hospice unit 9/15/21. Pt then died on 9/17/2021 at hospital during inpatient hospice admission. Per MD death note, "Death was caused by: Severe Protein-Calorie Malnutrition" Pt had received one covid vaccine on 4/9/2021. Death is not related to covid vaccine.
Nurse documented that a Hepatitis A adult dose was given when a pediatric/adolescent dose should have been administered.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 on 10/06/2022, 11/17/2022 and 04/27/2023. I never had a prescription for Paxlovid, but I took Tylenol, Advil, Mucinex and Sudafed to help with my symptoms. As of today, I have sinusitis and congestion.
Twenty-four hours after the first dose of the Pfizer vaccine, I began to experience some chest pain and pressure. I have never had heart issues before, so this was alarming. I went to the ER to get it checked out. It was there they told me I had some heart inflammation. Since that visit, I have also had these alarming symptoms, abnormal vaginal bleeding, irregular heart rating, lightheaded feeling and extreme fatigue. I had COVID before and it was nothing compared to this shot. I am five days post vaccine and I am still suffering.
About 18 hour after the vaccination I noted muscle aches, fever as high as 101.1, headache, fatigue, drowsiness and this lasted  for 36 hours except fatigue which has been worse than normal.
Information has been received from an approximately 63 year old male consumer with no pertinent medical history and no known drug reactions or allergies who in June 2010, was vaccinated with a dose of zoster vaccine live (Oka/Merck) (dose, route and Lot# not reported). Concomitant therapy included atorvastatin calcium (LIPITOR).  The consumer stated that "three weeks later" on approximately June 2010, he experienced herpes outbreak, then a month later on approximately July 2010, he experienced another herpes outbreak, and once more he had shingles rash and the pain that follows. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. Follow up information has been received on 19-JAN-2021, from a lawyer, regarding a case in litigation. It was confirmed that the patient was vaccinated with zoster vaccine live(ZOSTAVAX) and subsequently was treated by healthcare providers for the following injuries resulting from Plaintiff's zoster vaccine live(ZOSTAVAX) use: multiple outbreaks of herpes zoster, and postherpetic neuralgia. The outcome of post herpetic neuralgia and herpes zoster was unknown. Company Causality Assessment: Episode Profile: Medically Confirmed: N.
My tongue broke out in hives, I had mild swelling and dime-sized welts on my tongue. No trouble eating or drinking. MD thought that it was an autoimmune response. Lasted about 48 hours.
Post vaccination, the patient said her left eye felt funny. About 10 minutes later the felt her left arm felt heavy and her entire body became tingly. The patient's blood pressure was elevated 150/90. No treatment was given. The patient was observed for 1 1/2 hours.
CIDP; Cancer; Bells Palsy; Loss of eyesight/blurred vision; Loss of strength and problem with joints locking. Doc 214323, annual follow-up, states the followings: Razor sharp pain in feet, hands, disbling weakness and sometimes paralysis, memory loss, loss of concentration and confusion. Taking this vaccine has been the most devastating event of my life, it has crippled my body, my spirit and my life. I have been treated by appr. 8 medical experts, all concluded that the vaccine caused my various symptoms and illness. My doctors are professors of the most prestigious hospitals in the USA and none have been able to give me hope to return to a normal life and joy. Per doc 214442, patient had more tests and being checked for others things. Per follow-up, patient is often incoherent and currently undergoing many procedures.
arm started hurting and he couldn't move it and it kept going out; arm started hurting and he couldn't move it and it kept going out; just had a sting and a pain in the injection site; just had a sting and a pain in the injection site; soreness; This is a spontaneous report from a contactable consumer (patient) reported that. A 59-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), dose 2 via an unspecified route of administration on 25Mar2021 (at the age of 59 years old) as dose 2, single for on an unspecified indication. The patient medical history was not reported. There were no concomitant medications. On 21Jun2021, the patient experienced arm started hurting and he couldn't move it and it kept going out. The patient had the arm sting (25Mar2021) and pain at the injection site ((25Mar2021)), he was just having that and soreness (unknown date in 2021). But then on 21Jun2021 his arm went out and he guesses that he is not able to use the muscle in his arm and it just goes out on him. Like if he does something, sometimes he will reach out to open the door and it completely goes out. The sting and the pain started the day he received the injection, the COVID vaccine, and that was 25Mar2021 and that has been lasting from then up until 21Jun2021 when his arm started going out. He still has a little still that sting and it will be sore as well. He confirms that this is ongoing but now his arm goes out and sometimes he can't move it out. He says the sting and pain has gotten somewhat better. The outcome of the event arm started hurting and he couldn't move it and it kept going out was not recovered and the event just had a sting and a pain in the injection site outcome was recovering, and the event soreness was unknown.  Information on the lot/batch number has been requested.
Heart attack; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criterion medically significant). At the time of the report, MYOCARDIAL INFARCTION (Heart attack) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and Treatment were were not provided. Consent for follow-up declined.  have had 2 heart attacks and have cops.  Very limited information regarding this event has been provided at this time.   Further information is not expected.; Sender's Comments: Very limited information regarding this event has been provided at this time.   Further information is not expected
Severe headache at temples, unrelieved by Ibuprofen, chills, lethargy, red eye, pain and soreness at injection site--improved by next day except that tiredness/weakness remained for another 24 hours and local pain at injection site persisted four days +.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/2/2021 and 3/23/2021. PMHx CAD, HTN, severe obesity, DM2, Presented to the ED for AMS s/p fall 5 days prior w/progressive weakness. Admitted for COVID PNA and AKI. Altered mental status worsened along w/increased O2 demands requiring transfer to ICU and precedex. Intubated 12/21/2021, ischemic stroke and shock dx'd 12/23/21. Tx'd w/steroids, remdisivir, baricitinib, paralytics. and antibiotics. Expired 12/27/21.
loss of sense of smell; This is a spontaneous report from a Pfizer sponsored program, Pfizer COVID-19 Vaccine call center. This is a spontaneous report from a contactable consumer (68-year-old male) or other non hcp. A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 06Feb2021 (Batch/Lot number was not reported) as 1st dose, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced loss of sense of smell on Feb2021. Caller stated that wife loss of sense of smell around the same time he was diagnosed with Covid 19, although she never was tested. The outcome of event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
On 5/1/07 pt given MMRV, a combination vaccine not approved for her age. No known adverse consequence.
Temp. to 101.8 rectally after imms. Increased fussiness noted. No further complaints.
R arm: tenderness after vaccine.  Over the course of 3 months, worsening rotator cuff signs and symptoms including decrease range of motion Physical exam suggests supraspinatus tendinopathy Planning to start PT
can't eat; chills; headache; nausea; fever - 101.2; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (can't eat), CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and PYREXIA (fever - 101.2) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient had COVID in December.). Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced DECREASED APPETITE (can't eat), CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and PYREXIA (fever - 101.2). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (can't eat), CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and PYREXIA (fever - 101.2) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Hives on both anterior thighs developed within 3-5 minutes of vaccine administration. About 3 hive elevations on each thigh - located closest to injection site of KINRIX and Varicella. Recommended Benadryl pills and cream.
Chills, fever 101.1, body ache, heavy feeling, headaches, rash on face and neck  took Tylenol for fever headache s and chills.
10/25/99: after 1st Hep B shot pt. compl. of being hot with nausea, vomiting, diarrhea for 3 days. 11/29/99: after 2nd Hep B shot pt. compl. of neck being hot and severe bloody nose. 12/2/99: pt. compl. her neck hurt. 12/6: inj. site still inflam.
Patient was given the vaccine and a min or so after the vaccine was given called for help and then blacked out. Patient was having troubled breathing and turned pale.  Patient was given and injection of Epinephrine 0.3 mg to the right leg and 911 was called. After being checked out by EMS the patient declined going to the hospital for further treatment
This pharmacist reports that a 79 year old female consumer started taking PNEUMOVAX 23 (lot #669579/0595AA), dose, frequency and route unknown on 16SEP2012, for an unknown indication. The consumer's relevant medical history, concomitant medications, and past drug history are unknown. On 16SEP2012, the consumer was administered a PNEUMOVAX 23 that had expired on 30AUG2012. It is unknown if there is any relevant laboratory data. As of 16SEP2012, the outcome of receiving the expired vaccine is unknown, and it is unknown if the consumer continues to take PNEUMOVAX 23. Additional information has been requested.
pt recvd vax;pt indicated she had pain in arm from elbow to neck p/ shot;no swelling,redness or heat at site;chiropracter indicated to pt that this was an allergic rxn;
Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
PATIENT PASSED OUT ABOUT 15 MINUTES AFTER THE VACCINE WAS GIVEN.  THIS WAS NOTICED BY A SIGNIFICANT OTHER WITH THE PATIENT.  HE STATED THAT SHE WAS SHAKING FOR ABOUT 10 SECONDS.  PATIENT REGAINED CONSCIOUSNESS ABOUT 20 SECONDS AFTER PASSING OUT.  PATIENTS LIPS WERE BLUE WHEN SHE REGAINED CONSCIOUSNESS.  PATIENT HAD NO SIGNS OF ANAPHYLAXIS SO NO EPINEPHRINE WAS USED.
Patient received her 2nd booster on 6/1/2022. The staff at the Geriatric Center did not have record of this vaccination and it was not reported to the vaccination staff administering vaccines on 8/19/22. The patient received an unnecessary vaccination on 8/19/22, as she was not due for any more COVID-19 vaccines at this time. The nursing staff has not reported any adverse effects as of yet.